News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,022 Results
Type
Article (41546)
Company Profile (266)
Press Release (691197)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (205055)
Career Advice (2033)
Deals (35618)
Drug Delivery (132)
Drug Development (81642)
Employer Resources (173)
FDA (16544)
Job Trends (15001)
News (347213)
Policy (32771)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2606)
Accelerated approval (51)
Adcomms (28)
Allergies (173)
Alliances (49639)
ALS (213)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (479)
Approvals (16958)
Artificial intelligence (682)
Autoimmune disease (312)
Automation (57)
Bankruptcy (362)
Best Places to Work (11645)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (172)
Bladder cancer (201)
Brain cancer (73)
Breast cancer (776)
Cancer (6048)
Cardiovascular disease (486)
Career advice (1727)
Career pathing (43)
CAR-T (340)
CDC (57)
Celiac Disease (3)
Cell therapy (925)
Cervical cancer (49)
Clinical research (71152)
Collaboration (2102)
Company closure (5)
Compensation (1429)
Complete response letters (80)
COVID-19 (2750)
CRISPR (111)
C-suite (1160)
Cystic fibrosis (154)
Data (8219)
Decentralized trials (3)
Denatured (28)
Depression (164)
Dermatology (91)
Diabetes (604)
Diagnostics (6975)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (290)
Earnings (92213)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120251)
Executive appointments (1094)
FDA (20360)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1761)
Gene editing (239)
Generative AI (56)
Gene therapy (732)
GLP-1 (1061)
Government (4740)
Grass and pollen (6)
Guidances (412)
Healthcare (19118)
HIV (81)
Huntington's disease (57)
IgA nephropathy (103)
Immunology and inflammation (292)
Immuno-oncology (99)
Indications (198)
Infectious disease (3101)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (298)
Interviews (319)
IPO (16681)
IRA (50)
Job creations (3651)
Job search strategy (1431)
JPM (58)
Kidney cancer (20)
Labor market (105)
Layoffs (566)
Leadership (40)
Legal (7955)
Liver cancer (102)
Longevity (33)
Lung cancer (808)
Lymphoma (444)
Machine learning (60)
Management (59)
Manufacturing (1075)
MASH (199)
Medical device (13986)
Medtech (14118)
Mergers & acquisitions (20200)
Metabolic disorders (1544)
mRNA (217)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (432)
Neuropsychiatric disorders (106)
Neuroscience (3362)
Neurotech (1)
NextGen: Class of 2026 (6531)
Non-profit (4545)
Now hiring (79)
Obesity (716)
Opinion (291)
Ovarian cancer (231)
Pain (259)
Pancreatic cancer (319)
Parkinson's disease (373)
Partnered (33)
Patents (606)
Patient recruitment (693)
Peanut (62)
People (59730)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22181)
Phase 2 (31345)
Phase 3 (23330)
Pipeline (9149)
Policy (321)
Postmarket research (2570)
Preclinical (9438)
Press Release (64)
Prostate cancer (321)
Psychedelics (55)
Radiopharmaceuticals (337)
Rare diseases (1095)
Real estate (5979)
Recruiting (70)
Regulatory (25551)
Reports (56)
Research institute (2425)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (180)
Series A (293)
Series B (218)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3657)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (87)
The Weekly (63)
Vaccines (1116)
Venture capital (113)
Weight loss (459)
Women's health (128)
Worklife (20)
Date
Today (177)
Last 7 days (740)
Last 30 days (3269)
Last 365 days (30309)
2026 (13900)
2025 (30249)
2024 (35281)
2023 (40133)
2022 (51245)
2021 (55781)
2020 (54143)
2019 (46600)
2018 (35077)
2017 (32146)
2016 (31525)
2015 (37609)
2014 (31363)
2013 (26364)
2012 (28589)
2011 (29290)
2010 (27343)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (352)
Arkansas (14)
Asia (39838)
Australia (6527)
California (13605)
Canada (3841)
China (1407)
Colorado (576)
Connecticut (592)
Delaware (416)
Europe (86279)
Florida (2027)
Georgia (434)
Hawaii (3)
Idaho (63)
Illinois (1091)
India (92)
Indiana (613)
Iowa (23)
Japan (554)
Kansas (131)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1622)
Massachusetts (9682)
Michigan (370)
Minnesota (732)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (85)
New Jersey (3555)
New Mexico (29)
New York (3565)
North Carolina (1715)
North Dakota (9)
Northern California (6858)
Ohio (404)
Oklahoma (23)
Oregon (42)
Pennsylvania (2718)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5361)
Tennessee (215)
Texas (2160)
United States (47854)
Utah (402)
Vermont (1)
Virginia (324)
Washington D.C. (81)
Washington State (1082)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
733,022 Results for "paradigm biodevices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data
April 29, 2026
·
4 min read
Press Releases
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
May 5, 2026
·
4 min read
Press Releases
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
April 28, 2026
·
3 min read
Press Releases
Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer
May 19, 2026
·
12 min read
Press Releases
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant’s Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026
·
19 min read
Press Releases
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy
May 18, 2026
·
2 min read
Press Releases
From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson’s Disease
March 25, 2026
·
3 min read
Earnings
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods
Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its investigational obesity drug MariTide will continue to provide competitive weight loss even at monthly or longer schedules.
February 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
·
1 min read
Press Releases
Johnson & Johnson’s Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, versus hormone therapy alone, potentially shifting a decades-long treatment paradigm
June 1, 2026
·
13 min read
1 of 73,303
Next
